aristolochic acid i has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JM; Manchanda, R; Tsang, BK | 1 |
| Chen, PC; Huang, CC; Huang, CW; Yu, J | 1 |
2 other study(ies) available for aristolochic acid i and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
| Article | Year |
|---|---|
Role of prostaglandins in the suppression of apoptosis in hen granulosa cells by transforming growth factor alpha.
Topics: Alprostadil; Animals; Apoptosis; Arachidonic Acid; Arachidonic Acids; Aristolochic Acids; Cells, Cultured; Chickens; Chromatin; Culture Media, Serum-Free; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; DNA Fragmentation; Enzyme Inhibitors; Female; Granulosa Cells; Ibuprofen; Nitrobenzenes; Phenanthrenes; Phospholipases A; Prostaglandins; Prostaglandins E; Prostaglandins F; Sulfonamides; Transforming Growth Factor alpha | 2001 |
Aristolochic Acid induces heart failure in zebrafish embryos that is mediated by inflammation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aristolochic Acids; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Embryo, Nonmammalian; Endocardium; Gene Expression; Gene Expression Regulation, Developmental; Heart; Heart Failure; Inflammation; Isoproterenol; Metoprolol; Mutagens; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Nitrobenzenes; Sulfonamides; Zebrafish | 2007 |